|
2000 Conference Publication Cystic fibrosis liver disease and liver biopsy: improved accuracy of assessment with dual samplingLewindon, P. J., Walker, N. I., Williamson, R., Smith, J. L., Pereira, T. N., Shepherd, R. W. and Ramm, G. A. (2000). Cystic fibrosis liver disease and liver biopsy: improved accuracy of assessment with dual sampling. Australian Gastroenterology Week 2000, Hobart, 18-21 Oct, 2000. Asia: Blackwell Science. |
|
1999 Journal Article Activation of pancreatic stellate cells in human and experimental pancreatic fibrosisHaber, P. S., Keogh, G. W., Apte, M. V., Moran, C. S., Stewart, N. L., Crawford, D. H. G., Pirola, R. C., McCaughan, G. W., Ramm, G. A. and Wilson, J. S. (1999). Activation of pancreatic stellate cells in human and experimental pancreatic fibrosis. American Journal of Pathology, 155 (4), 1087-1095. doi: 10.1016/S0002-9440(10)65211-X |
|
1999 Journal Article Elevated serum type IV collagen: a sensitive indicator of the presence of cirrhosis in haemochromatosisGeorge, D. Keith, Ramm, Grant A., Walker, Neal I., Powell, Lawrie W. and Crawford, Darrell H. G. (1999). Elevated serum type IV collagen: a sensitive indicator of the presence of cirrhosis in haemochromatosis. Journal of Hepatology, 31 (1), 47-52. doi: 10.1016/S0168-8278(99)80162-7 |
|
1999 Conference Publication Hepatic fibrogenesis in cystic fibrosis liver diseaseBlanch, N. L., Bridle, K., Greco, S., Lewindon, P., Murphy, T. M., Pereira, T., Ramm, G. A., Shepherd, R. W., Smith, J. L. and Walker, N. I. (1999). Hepatic fibrogenesis in cystic fibrosis liver disease. 50th Annual Meeting and Postgraduate Conference, Dallas, Texas, Nov 1999. USA: Harcourt and Brace (WD Saunders). |
|
1999 Conference Publication Identification and characterisation of the hepatic stellate cell transferrin receptor and influence of transferrin on hepatic stellate cell activationBridle, K., Stewart, N. L., Crawford, D. H., Anderson, G. and Ramm, G. A. (1999). Identification and characterisation of the hepatic stellate cell transferrin receptor and influence of transferrin on hepatic stellate cell activation. Bioiron'99, Sorrento Palace, Sorrento-Naples, Italy, 23 - 28 May 1999. Italy: SGC. |
|
1999 Conference Publication Serum hyaluronic acid and collagen type IV as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseases American Association for the Study of Liver Diseases (AASLD) 50th annual meeting. Texas, USA. November 5-9, 1999.Ramm, G.A., Murphy, T.L., Fanning, P.A., Clouston, A.D., Anderson, G.J. and Crawford, D.H. (1999). Serum hyaluronic acid and collagen type IV as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseases American Association for the Study of Liver Diseases (AASLD) 50th annual meeting. Texas, USA. November 5-9, 1999.. 50th Annual Meeting American Association for the Study of Liver Disease, Dallas, TX, United States, 5-9 November 1999. Hoboken, NJ, United States: John Wiley & Sons. |
|
1999 Conference Publication Identification and characterisation of a receptor for transferrin on hepatic stellate cells: role in the transformation to myofibroblastsBridle, K., Blanch, N. L., Crawford, D. H. and Ramm, G. A. (1999). Identification and characterisation of a receptor for transferrin on hepatic stellate cells: role in the transformation to myofibroblasts. Australian Gastroenterology Week 1999, Brisbane, 4 - 8 Oct, 1999. Carlton, Vic: Blackwell Science Asia. |
|
1999 Conference Publication Hepatic stellate cells are responsible for increased type I collagen production leading to cirrhosis in cystic fibrosis liver diseaseBlanch, N. L., Greco, S., Lewindon, P., Ramm, G. A., Shepherd, R. W., Smith, J. L. and Walker, N. I. (1999). Hepatic stellate cells are responsible for increased type I collagen production leading to cirrhosis in cystic fibrosis liver disease. Australian Gastroenterology Week 1999, Brisbane, 4 - 8 October, 1999. Carlton, Vic: Blackwell Science. |
|
1999 Conference Publication Hepatic iron overload in pathogen-free gerbils does not result in bridging fibrosis or cirrhosisRamm, G. A., Britton, R. S., Brunt, E. M., O'Neil, R. and Bacon, B. R. (1999). Hepatic iron overload in pathogen-free gerbils does not result in bridging fibrosis or cirrhosis. Bioiron'99, Sorrento Palace, Sorrento - Naples, Italy, 23 - 28 May 1999. Italy: SGC. |
|
1999 Journal Article HaemochromatosisCrawford, D. H. G. and RammGA (1999). Haemochromatosis. Trends in Endocrinology and Metabolism, 10 (1), 14-17. doi: 10.1016/S1043-2760(98)00103-9 |
|
1999 Conference Publication Serum hyaluronic acid is a sensitive marker of both cirrhosis in haemochromatosis and liver injury in other chronic liver diseasesRamm, G. A., Murphy, T. L., Fanning, P. A., Clouston, A. D., George, D. K., Fletcher, L. M., Anderson, G., Powell, L. W. and Crawford, D. H. (1999). Serum hyaluronic acid is a sensitive marker of both cirrhosis in haemochromatosis and liver injury in other chronic liver diseases. Australian Gastroenterology Week 1999, Brisbane, 4 - 8 October,1999. Carlton, Vic: Blackwell Science Asia. |
|
1999 Conference Publication Evaluation of serum TIMP-1 collagen type IV and MMP-2 as markers of hepatic fibrogenesis in cystic fibrosis liverLewindon, P., Murphy, T. M., Pereira, T., Ramm, G. A., Shepherd, R. W. and Smith, J. L. (1999). Evaluation of serum TIMP-1 collagen type IV and MMP-2 as markers of hepatic fibrogenesis in cystic fibrosis liver. Australian Gastroenterology Week 1999, Brisbane, Australia, 4-8 October 1999. Carlton, Vic: Blackwell Science. |
|
1999 Conference Publication Serum hyaluronic acid and collagen type IV as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseasesRamm, G. A., Murphy, T. L., Fanning, P. A., Clouston, A. D., George, D. K., Fletcher, L. M., Anderson, G., Powell, L. W. and Crawford, D. H. (1999). Serum hyaluronic acid and collagen type IV as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseases. American Assoc. for the Study of Liver Diseases 50th Annual Meeting, Dallas, Texas, USA, 5 - 9 Nov, 1999. USA: W B Saunders Co.. |
|
1999 Conference Publication Activated hepatic stellate cells produce increased collagen type I in patients with cystic fibrosis liver diseaseSmith, J. L., Ramm, G. A., Lewindon, P. and Blanch, N. L. (1999). Activated hepatic stellate cells produce increased collagen type I in patients with cystic fibrosis liver disease. Basel, Switzerland, Oct 1999. Switzerland: Congress for Liver Disease. |
|
1999 Journal Article Genetics of hemochromatosisCullen, L. M., Anderson, G. J., Ramm, G. A., Jazwinska, E. C. and Powell, L. W. (1999). Genetics of hemochromatosis. Annual Review of Medicine, 50 (1), 87-98. doi: 10.1146/annurev.med.50.1.87 |
|
1999 Conference Publication Hepatic stellate cells and hepatic fibrogenesis in cystic fibrosis liver diseaseGreco, S., Lewindon, P., Ramm, G. A. and Shepherd, R. W. (1999). Hepatic stellate cells and hepatic fibrogenesis in cystic fibrosis liver disease. Thirteenth Annual North American Cystic Fibrosis Conference, Washington State Convention and Trade Cen., Seattle, Washington USA, 7 - 10 October, 1999. California, USA: Wiley-Liss. doi: 10.1002/(SICI)1099-0496(199909)28:19 |
|
1999 Conference Publication Serum collagen type IV and hyaluronic acid as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseasesRamm, G. A., Murphy, T. L., Fanning, P. A., Clouston, A. D., George, D. K., Fletcher, L. M., Anderson, G., Powell, L. W. and Crawford, D. H. (1999). Serum collagen type IV and hyaluronic acid as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseases. Bioiron'99, Sorrento Palace, Sorrento - Naples, Italy, 23 - 28 May 1999. Italy: SGC. |
|
1998 Journal Article Contribution of hepatic parenchymal and nonparenchymal cells to hepatic fibrogenesis in biliary atresiaRamm, G. A., Nair, V. G., Bridle, K. R., Shepherd, R. W. and Crawford, D. H. G. (1998). Contribution of hepatic parenchymal and nonparenchymal cells to hepatic fibrogenesis in biliary atresia. American Journal of Pathology, 153 (2), 527-535. doi: 10.1016/S0002-9440(10)65595-2 |
|
1998 Journal Article Evidence for altered hepatic matrix degradation in genetic haemochromatosisGeorge, D.K., Ramm, G.A., Powell, L.W., Fletcher, L.M., Walker, N.I., Cowley, L.L. and Crawford, D.H.G. (1998). Evidence for altered hepatic matrix degradation in genetic haemochromatosis. Gut, 42 (5), 715-720. doi: 10.1136/gut.42.5.715 |
|
1998 Conference Publication The contribution of inflammatory cells to iron-induced hepatic fibrogenesis in hemochromatosisBridle, K. R., Crawford, D. H. G., Smith, J. L., Fletcher, L. M., Walker, N. I. and Ramm, G. A. (1998). The contribution of inflammatory cells to iron-induced hepatic fibrogenesis in hemochromatosis. 49th Annual Meeting of the American Association for the Study of Liver Disease, Chicago, Il, United States, 6-10 November 1998. Hoboken, NJ, United States: John Wiley & Sons. |
